DARPP-32 neuronal signaling is critical for motivated behavior, learning and memory and is also associated to pathogenic conditions such as schizophrenia and addictions, DARPP-32 has been considered for therapeutic targeting in various neurobehavioral disorders [54]. The gene discussed is PPP1R1B; the disease is schizophrenia.